Zouina Sarfraz, Postdoctoral Research Fellow in Oncology at the Miami Cancer Institute, shared a post on LinkedIn:
“Aloha from Hawaii
Honored to present a mini-oral today at SNO2025, sharing our meta-analysis on the effectiveness and safety of dual immune checkpoint inhibitors in melanoma brain metastases – an area where strong, consolidated evidence is still limited but critically needed to guide care.
This project has been a rewarding deep dive into a rapidly evolving space, and I’m grateful for the opportunity to contribute to ongoing efforts to refine and optimize immunotherapy strategies for patients with CNS involvement.
A heartfelt thank you to Manmeet Ahluwalia for his exceptional mentorship, support, and for championing this work from the very beginning. Truly grateful.”
More posts from Zouina Sarfraz on OncoDaily.